A court sided with Medtronic (NYSE:MDT), overturning a 2023 verdict ordering the medtech giant to pay a significant amount in ...

Hyperfine (Nasdaq:HYPR) announced that it made the first commercial sales of its next-generation Swoop system powered by new ...

Nuwellis terminated its REVERSE‑HF randomized trial comparing ultrafiltration with IV loop diuretics in hospitalized heart ...

RadNet today announced it completed the purchase of iCAD, adding the breast-imaging AI developer to RadNet’s DeepHealth ...

With the launch, Anumana became the first organization to utilize the marketplace. Philips now plans to make offer the ...

Xeltis today announced encouraging preliminary data for its Xabg coronary artery bypass conduit (CABG) device.

Saluda Medical today announced the full launch of its EVA next-generation sensing technology for its neuromodulation therapy.

UroMems received FDA investigational device exemption (IDE) approval to begin a first-of-its-kind trial for its smart implant ...

Paradromics announced today that it selected a third investigator for its upcoming brain-computer interface (BCI) clinical ...

Exactech today announced it appointed Dr. Richard J. Friedman as chief medical officer, effective immediately.

Abbott (NYSE: ABT) shares dipped before hours today on second-quarter results that came in ahead of the consensus forecast.

Medtronic (NYSE: MDT) today announced the first patient enrolled in the PELE trial of its Onyx liquid embolic system (LES).